BIOMAT Database Logo BIOMAT Database Logo

Analysis of rejection in cyclosporine-treated cardiac allograft recipients. 1988

M P Macris, and O H Frazier, and T Burstein, and H A McAllister, and C T Van Buren
Division of Surgery, Texas Heart Institute, Houston 77225.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007959 Lymphocyte Culture Test, Mixed Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Leukocyte Culture Test, Mixed,Mixed Lymphocyte Culture Test,Mixed Lymphocyte Reaction,Mixed Leukocyte Culture Test,Mixed Leukocyte Reaction,Leukocyte Reaction, Mixed,Leukocyte Reactions, Mixed,Lymphocyte Reaction, Mixed,Lymphocyte Reactions, Mixed,Mixed Leukocyte Reactions,Mixed Lymphocyte Reactions
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016027 Heart Transplantation The transference of a heart from one human or animal to another. Cardiac Transplantation,Grafting, Heart,Transplantation, Cardiac,Transplantation, Heart,Cardiac Transplantations,Graftings, Heart,Heart Grafting,Heart Graftings,Heart Transplantations,Transplantations, Cardiac,Transplantations, Heart

Related Publications

M P Macris, and O H Frazier, and T Burstein, and H A McAllister, and C T Van Buren
Predictors of rejection in cyclosporine-treated cardiac allograft recipients.
February 1987, Transplantation proceedings,
M P Macris, and O H Frazier, and T Burstein, and H A McAllister, and C T Van Buren
T-lymphocyte analysis in cardiac allograft recipients treated with cyclosporine.
November 1986, The Annals of thoracic surgery,
M P Macris, and O H Frazier, and T Burstein, and H A McAllister, and C T Van Buren
Determinants of chronic renal allograft rejection in cyclosporine-treated recipients.
November 1996, Transplantation,
M P Macris, and O H Frazier, and T Burstein, and H A McAllister, and C T Van Buren
Increase in natural killer activity in cyclosporine-treated renal allograft recipients during rejection.
June 1987, Human immunology,
M P Macris, and O H Frazier, and T Burstein, and H A McAllister, and C T Van Buren
Analysis of pharmacokinetic profiles in 232 renal and 87 cardiac allograft recipients treated with cyclosporine.
December 1986, Transplantation proceedings,
M P Macris, and O H Frazier, and T Burstein, and H A McAllister, and C T Van Buren
Leukocyturia in cyclosporine-treated renal allograft recipients.
January 1988, American journal of clinical pathology,
M P Macris, and O H Frazier, and T Burstein, and H A McAllister, and C T Van Buren
T cell subset analysis predicts virus infection but not rejection in cyclosporine A-treated renal allograft recipients.
February 1987, Transplantation proceedings,
M P Macris, and O H Frazier, and T Burstein, and H A McAllister, and C T Van Buren
Effects of prophylactic rabbit antithymocyte globulin in cardiac allograft recipients treated with cyclosporine.
January 1987, The Journal of heart transplantation,
M P Macris, and O H Frazier, and T Burstein, and H A McAllister, and C T Van Buren
Immunoregulatory mechanisms in cyclosporine-treated renal allograft recipients.
February 1987, Transplantation,
M P Macris, and O H Frazier, and T Burstein, and H A McAllister, and C T Van Buren
Immunopharmacodynamic evaluation of cyclosporine-treated renal allograft recipients.
December 1984, Transplantation,
Copied contents to your clipboard!